• All
• Nov. 28(Thu)
• Nov. 29(Fri)
• Nov. 30(Sat)

• Basic/Translational Symposium
• Big Data Research
• Combined Symposium
• Gender Specific Medicine in Gastroenterology
• In-depth Symposium
• Joint Symposium
• Korean GI Frontier
• Meet the Professor
• Metabolism & Obesity
• Multidisciplinary Session
• Nursing Session
• PG Course
• Presidential & Special Lecture
• Primary Care Session
• Symposium
• Video Session
• Plenary Session
• Topic Forum
• E-poster Oral
• General Meeting
• Editor Session
• Free Paper
• E-poster Exhibition
• Luncheon Symposium
• Breakfast Symposium

E-poster Oral 01-1 (PB1)  English 

Nov. 28(Thu)		Flamingo (Main 2F)
Chair(s)	Dae Hwan Kang (Korea), Byoung Kwan Son (Korea)
11:00-11:08	Litholytic agents as an alternative treatment modality in patients with biliary dyspepsia	Young Min Kim (Korea)
11:08-11:16	AGT score as a predictor of common bile duct stone using endoscopic ultrasound (EUS) in patients with intermediate probability criteria according to ASGE guidelines	Muhammad Manzoor Ul Haq (Pakistan)
11:16-11:24	Changes of bacteriobilia and clinical outcome in patients with biliary infection	Jai Hoon Yoon (Korea)
11:24-11:32	Benefits and pitfalls of surgical resection after downstaging concurrent chemoradiation therapy in patients with locally advanced perihilar cholangiocarcinoma	Incheon Kang (Korea)
11:32-11:40	Predictive biomarkers in the gemcitabine plus cisplatin for unresectable or recurrent biliary tract cancer: a single-center, prospective study	Boyoung Lee (Korea)

E-poster Oral 01-2 (PB1)  Korean 

Nov. 28(Thu)		Flamingo (Main 2F)
Chair(s)	Eun Kwang Choi (Korea), Dong Kee Jang (Korea)
11:40-11:48	High PD-L1 expression is associated with response to pembrolizumab in patients with advanced biliary tract cancer	Dong Woo Shin (Korea)
11:48-11:56	Efficacy and safety of Pembrolizumab for gemcitabine/cisplatin-refractory biliary tract cancer: multicenter retrospective study	Sang Hoon Lee (Korea)
11:56-12:04	Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma	Hyo Jung Kim (Korea)
12:04-12:12	Which is the determining factor for selection of the antimicrobial agent in patient with acute cholangitis, bile or blood?	HyoJin Kwon (Korea)
12:04-12:20	Side-by-Side Simultaneous Insertion of Covered Metal Stent and Plastic Stent for Malignant Biliary Obstruction: A Pilot Study for Efficacy, Patency and Safety	Jae Ok Park (Korea)

E-poster Oral 02-1 (LGI1)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Byung Ik Jang (Korea), Hyun Jung Lee (Korea)
11:00-11:08	Comparison of conventional and modified endoscopic mucosal resections for the treatment of rectal neuroendocrine tumors	Hee Sung Lee (Korea)
11:08-11:16	Patterns of seroid use in Korean patients with inflammatory bowel disease	Yehyun Park (Korea)
11:16-11:24	Comparison of bowel-cleansing efficacy of spit-dose and same-day dose bowel preparation for afternoon colonoscopy in patients with gastrectomy: a prospective randomized study	Tae-Geun Gweon (Korea)
11:24-11:32	Characterization of Intestinal Microbic and Metabolic Microenvironment Signatures of Inflammatory Bowel Disease	Shengtao Zhu (China)
11:32-11:40	A Multicenter, Open-label, Controlled, Randomized Study Comparing 4g Once Daily with 2g Two Times Daily Prolonged-release Mesalamine for Mild to Moderate active Ulcerative Colitis	Kang-Moon Lee (Korea)

E-poster Oral 02-2 (LGI1)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Jong Pil Im (Korea), Sang-Bum Kang (Korea)
11:40-11:48	Dipstick proteinuria predicts the development of Crohn's disease: a Nationwide Population-based Study	Seona Park (Korea)
11:48-11:56	Modified Enhanced Recovery after Surgery (mERAS) in colorectal surgery: Outcome of novel experience in colorectal surgery in a limited resource setting in South Asia	Chamila Lakmal (Sri Lanka)
11:56-12:04	Effect of Faecal Microbiota Transplantation on Clearance of Carbapenemase-producing Enterobacteraceae.	Boram CHA (Korea)
12:04-12:12	NUDT15 intermediate metabolizers are associated with longer infliximab durability in pediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine	Eun Sil Kim (Korea)

E-poster Oral 03-1 (UGI1)  Korean 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Hyungkil Kim (Korea)
11:00-11:08	OLGA and OLGIM stage for the prediction of metachronous gastric neoplasia after endoscopic resection in Helicobacter pylori negative early gastric cancer patients	Jun Hyuk Kang (Korea)
11:08-11:16	Pre-procedural features for predicting the risk of lymph node metastasis in early gastric cancer	Dong-Jun Kim (Korea)
11:16-11:24	Favorable Long-term Outcomes of Endoscopic Submucosal Dissection for Differentiated-type-Predominant Early Gastric Cancer with Histological Heterogeneity	Tae-Se Kim (Korea)
11:24-11:32	Development of Endoscopic Scoring System to Predict Risk of Intestinal type Gastric Cancer: Preliminary prospective study	Hee Kyong Na (Korea)
11:32-11:40	Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma	Ga Hee Kim (Korea)

E-poster Oral 03-2 (UGI1)  English 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Byung-Wook Kim (Korea), Chan Gyoo Kim (Korea)
11:40-11:48	Accuracy of Endoscopic Ultrasound (EUS) for superficial esophageal cancer and factors affecting overstaging.	Jinju Choi (Korea)
11:48-11:56	Clinical significance of simulation CT images during definitive chemoradiotherapy in locally advanced esophageal cancer	Jungi Yeom (Korea)
11:56-12:04	Comparison between gastrostomy and self-expandable metal stent for malignant esophageal obstruction, after propensity score matching	Joo Hye Song (Korea)
12:04-12:12	Clinical Outcomes of Mucinous Gastric Carcinomas Compared with Non-mucinous and Signet Ring Cell Carcinomas	Honggeun Ahn (Korea)
12:12-12:20	Mucosal transplantation for the management of stricture after endoscopic submucosal dissection	Saif Ullah (China)

E-poster Oral 04-1(PB2)  English 

Nov. 28(Thu)		Flamingo (Main 2F)
Chair(s)	Jong Jin Hyun (Korea), Dong Wook Lee (Korea)
14:00-14:08	Early Nasogastric tube feeding VS Nil per oral in mild to moderate Acute Pancreatitis	Akhilesh Kasyap (Korea)
14:08-14:16	Analysis of optimal procedure time to prevent post-ERCP pancreatitis using decision tree analysis: a retrospective single center analysis	Chang-Min Cho (Korea)
14:16-14:24	Incidence of pancreatic duct injury in pseudocyst and WON: a systematic review.	Yutthaya Ounklin (Thailand)
14:24-14:32	Prognostic value of the cytokine profile in diseases of the pancreas	Saidrakhim Nodirovich Lukmonov (Uzbekistan)
14:32-14:40	Response of pancreatic ductal adenocarcinoma to gemcitabine using human organotypic slice culture model	Jae Hyuck Chang (Korea)

E-poster Oral 04-2 (PB2)  English 

Nov. 28(Thu)	E-poster Oral (PB2)	Flamingo (Main 2F)
Chair(s)	Hyo Jung Kim (Korea), Jimin Han (Korea)
14:40-14:48	EUS-guided pancreatic ductal adenocarcinoma organoid creation	Khanh Cong Pham (Thailand)
14:48-14:56	Correlation of clinical syndromes of chronic pancreatitis depending on the duration of the disease	Saidrakhim Lukmonov (Uzbekistan)
14:56-15:04	Antibiotics for mild to moderately severe acute pancreatitis with fever	Jin Myung Park (Korea)
15:04-15:12	Pancreatic duct stent without pancreatogram may reduce post-ERCP pancreatitis than pancreatic duct stent with pancreatogram	Jae Hyuck Jun (Korea)

E-poster Oral 05-1 (LGI2)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Hyungkil Kim (Korea), Chang-Kyun Lee (Korea)
14:00-14:08	Clinical Characteristics of Campylobacter Enterocolitis in Korean adults: A retrospective study in a single center	Minseok Yoo (Korea)
14:08-14:16	TL1A affected epithelial-mesenchymal transition in intestinal mucosal epithelial cells of patients with IBD-related intestinal fibrosis	Wenxiu Jia (China)
14:16-14:24	Clinical significance of patch distribution of residual inflammation in UC patients with clinical remission.	Jongbeom Shin (Korea)
14:24-14:32	Clinical outcomes after discontinuation of anti-tumor necrosis factor- agents in inflammatory bowel disease patients with clinical remission: KASID multicenter study	Joo Hye Song (Korea)

E-poster Oral 05-2 (LGI2)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Jeong-Seon Ji (Korea), Won Moon (Korea)
14:32-14:40	Red Rice Extract Ameliorates Inflammation in an Ulcerative Colitis Model	Napapan Kangwan (Thailand)
14:40-14:48	Allergic rhinitis induced colonic mucosal immune activation in murine model ; Association between Allergic rhinitis and Irritable bowel syndrome	Sang Hyun Kim (Korea)
14:48-14:56	ACTG2 gene mutation and clinical features in patients with chronic intestinal pseudo-obstruction	Jong Woo Hahn (Korea)

E-poster Oral 06-1 (UGI2)  English 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Sung Kook Kim (Korea), Gwang Ho Baik (Korea)
14:00-14:08	H.PYLORI PREVALENCE IN MONGOLIA BY USING C14 UREA BREATH TEST	Suvd Tumurbaatar (Mongolia)
14:08-14:16	Correlation of Clinical and Endoscopic Findings in Patients with Helicobacter Pylori Infection using Rapid Urease Test: A 10-year Retrospective Study	Virgilio Jr. Sandico Lo (Philippines)
14:16-14:24	Can DPO-PCR based tailored-therapy increase the eradication rate of Helicobacter pylori?	Youngwoo Kim (Korea)
14:24-14:32	Changes in eradication efficacy of fluoroquinolone-containing triple therapy to Helicobacter pylori in Korea	Nayoung Kim (Korea)

E-poster Oral 06-2 (UGI2)  English 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Ok-Jae Lee (Korea)
14:32-14:40	Combination therapy with PI3K/mTOR dual inhibitor and chloroquine enhances synergistic apoptotic cell death in EBV-infected gastric cancer cells	Miyoung Kim (Korea)
14:40-14:48	MMP-7 expression predicts a poor prognosis in patients with gastric cancer	Taweesak Tongtawee (Thailand)
14:48-14:56	Deep learning with long short-term memory to predict gastric neoplasm in asymptomatic population after a health check-up	Hong Jin Yoon (Korea)
14:56-15:04	Comparison of intestinal vs diffuse type gastric cancer from the perspective of large-scale signaling network	Jun Hyuk Kang (Korea)